Table 4.

CVD biomarker IPV +\− cross correlation.

IPV + Samples (Spearman’s rho)	sCD40L (pg/ml)	IL-1b (pg/ml)	IL - 6 (pg/ml)	TNF-a (pg/ml	Adiponectin (pg/ml)	PAI-1 (pg/ml	MMP9 (pg/ml)	Myoglobin (ng/ml)	sICAM-1 (pg/ml)	CRP (mg/ml)
sCD40L (pg/ml)		0.137	0.270	0.056	0.696	0.413	0.706	0.766	0.468	0.788
IL - 1b (pg/ml)	0.031		0.020	0.045	0.002	0.013	0.000	0.044	0.294	0.026
IL - 6 (pg/ml)	0.166	0.000		0.014	0.016	0.088	0.100	0.795	0.908	0.969
TNF-a (pg/ml	0.039	0.000	0.002		0.092	0.146	0.068	0.713	0.184	0.586
Adiponectin (pg/ml)	0.252	0.001	0.003	0.003		0.008	0.001	0.023	0.524	0.168
PAI-1 (pg/ml	0.336	0.000	0.000	0.003	0.001		0.025	0.004	0.106	0.030
MMP9 (pg/ml)	0.128	0.006	0.047	0.002	0.014	0.000		0.081	0.086	0.057
Myoglobin (ng/ml)	0.863	0.013	0.006	0.025	0.000	0.007	0.064		0.185	0.024
sICAM-1 (pg/ml)	0.067	0.000	0.006	0.000	0.001	0.001	0.003	0.008		0.144
CRP (mg/ml)	0.036	0.000	0.000	0.001	0.060	0.000	0.022	0.183	0.001

Cross comparison of Cross Correlated CVD Biomarkers in IPV+ and IPV− participants. Left side right triangle area represents the significance of Cross Correlated CVD Biomarkers among IPV + participants represented in p-values. Right sided upside down triangle represents the significance of Cross Correlated CVD Biomarkers among IPV− participants represented in p-values. Bolded black p-values in corresponding IPV group represent significant correlation to that IPV group. Significance (P < 0.05).